Mrv1909 02132015542D 14 13 0 0 0 0 999 V2000 2.5005 0.8249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.5005 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2150 -0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7862 -0.4125 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.7862 -1.2374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3571 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 -0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 0.8249 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.5005 -0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 1.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2150 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 3 2 1 0 0 0 0 4 2 1 0 0 0 0 4 5 1 1 0 0 0 6 4 1 0 0 0 0 7 6 1 0 0 0 0 9 8 1 0 0 0 0 7 8 1 0 0 0 0 10 9 1 0 0 0 0 11 10 2 0 0 0 0 12 10 1 0 0 0 0 11 13 1 0 0 0 0 12 14 1 0 0 0 0 M END > DB02302 > drugbank > CN\C(NCCC[C@H](N)C(O)=O)=N\C > InChI=1S/C8H18N4O2/c1-10-8(11-2)12-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H,13,14)(H2,10,11,12)/t6-/m0/s1 > HVPFXCBJHIIJGS-LURJTMIESA-N > C8H18N4O2 > 202.2541 > 202.14297584 > 6 > 32 > 0.9924695256359154 > 21.776033274437594 > 1 > 4 > 0 > 0 > (2S)-2-amino-5-[(Z)-N',N''-dimethylcarbamimidamido]pentanoic acid > -2.94 > -2.654929684285306 > -2.11 > 0 > 1 > 0 > 1 > 2.5397284499921273 > 12.401054141729825 > 99.74 > 53.1795 > 5 > 1 > 1.56e+00 g/l > 2-oxo-4-thiomethylbutyric acid > 0 > DB02302 > EXPT00132 > experimental > Symmetric dimethylarginine > (S)-2-amino-5-(N',N''-dimethylguanidino)pentanoic acid; Guanidino-N(1),N(2)-dimethylarginine; N(G1),N(G2)-Dimethylarginine; N3,N4-dimethyl-L-arginine; N3,N4-dimethylarginine; NG,N'G-dimethylarginine; SDMA $$$$